Mingowood Pharmacal

Mingowood PharmacalMingowood PharmacalMingowood Pharmacal
  • Home
  • Mission
  • Benefits
  • Better Medicine
  • Technology
    • Our Science
    • Demonstration
    • Stability Studies
    • ATR-FTIR
    • Product Pipeline
    • Patents
    • FAQ
  • About
    • Monetization Model
    • Announcements
    • Leadership
  • Contact
  • More
    • Home
    • Mission
    • Benefits
    • Better Medicine
    • Technology
      • Our Science
      • Demonstration
      • Stability Studies
      • ATR-FTIR
      • Product Pipeline
      • Patents
      • FAQ
    • About
      • Monetization Model
      • Announcements
      • Leadership
    • Contact

Mingowood Pharmacal

Mingowood PharmacalMingowood PharmacalMingowood Pharmacal
  • Home
  • Mission
  • Benefits
  • Better Medicine
  • Technology
    • Our Science
    • Demonstration
    • Stability Studies
    • ATR-FTIR
    • Product Pipeline
    • Patents
    • FAQ
  • About
    • Monetization Model
    • Announcements
    • Leadership
  • Contact

Patent Timeline

    

Priority date (US provisional patent filed) - October 2020


US/PCT patent application filed - October 2021 


PCT Search Report issued - February 2022


International patent application published - April 2022


US patent application published - April 2023


US patent issued - August 2025

 

  • Stabilization  of acidic cannabinoids -- CBDA, THCA, CBGA, etc. --  against decarboxylation
  • Stabilization of same against oxidation and other degradation reactions through chelation in laminar structure.
  • Cannabinoids encapsulated in their unaltered, natural phytochemical form--no covalent modifications are made.
  • Over 50 vol% loading and >90% encapsulation efficiency.
  • High oral bioavailability.
  • Conversion of sticky, resinous cannabinoids to flowable solid powders.
  • Selective extraction and concomitant purification of acidic cannabinoids from plant, bioreactor, and synthesized materials.
  • Taste-masking has been achieved
    Products inherit the long shelf life (i.e., two years at room temperature)
  • Patent priority date of October 2020, putting expiration in 2040


Mingowood Pharmacal

Copyright © 2024 Mingowood Pharmacal - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept